Get the app!
Back to Trades

Blume-Jensen Peter

InsiderCIK 0001950499

Largest Purchase

$82.1K

Acrivon Therapeutics, Inc. (ACRV)

Jan 16

Profile

Filings
9
Buy transactions
1
Sell transactions
0
Companies
1
Active
2025–2026

Across 9 filings between 2025–2026, Blume-Jensen Peter has disclosed $403.9K in transactions — all concentrated in Acrivon Therapeutics, Inc. (ACRV). Their disclosed trades are heavily weighted toward buying$82.1K in buys and $0 in sells. The largest single open-market purchase on record is $82.1K in Acrivon Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

9 loaded
May 26ACRV
Acrivon Therapeutics, Inc.
Blume-Jensen PeterInsiderTax withheld$24.6K
May 20ACRV
Acrivon Therapeutics, Inc.
Blume-Jensen PeterInsiderGrant$0
May 18ACRV
Acrivon Therapeutics, Inc.
Blume-Jensen PeterInsiderTax withheld$3.3K
Feb 18ACRV
Acrivon Therapeutics, Inc.
Blume-Jensen PeterInsiderTax withheld$3.1K
Jan 16ACRV
Acrivon Therapeutics, Inc.
Blume-Jensen PeterInsiderBuy$82.1K
Nov 25ACRV
Acrivon Therapeutics, Inc.
Blume-Jensen PeterInsiderTax withheld$45.8K
Nov 18ACRV
Acrivon Therapeutics, Inc.
Blume-Jensen PeterInsiderTax withheld$135.0K
Aug 25ACRV
Acrivon Therapeutics, Inc.
Blume-Jensen PeterInsiderTax withheld$26.3K
Aug 18ACRV
Acrivon Therapeutics, Inc.
Blume-Jensen PeterInsiderTax withheld$83.8K

9 filings